Click Here to Go Directly to the Story

 
 


U.S. EDITION
Full Table of Contents
Cover Story
Up Front
Readers Report
Corrections & Clarifications
Books
Technology & You
Economic Trends
Economic Viewpoint
Business Outlook
News: Analysis & Commentary

In Business This Week
Washington Outlook
International Business
International Outlook
Government
Developments to Watch
Science & Technology
Information Technology
The Workplace
Finance

Entertainment
The Corporation
BusinessWeek Investor
BusinessWeek Lifestyle
The Barker Portfolio
Inside Wall Street
Figures of the Week
Editorials


INTERNATIONAL EDITIONS
International -- Int'l Cover Story
International -- Readers Report
International -- Asian Business
International -- European Business
International -- Finance
International -- Int'l Figures of the Week
International -- Editorials




JULY 15, 2002

SCIENCE & TECHNOLOGY
By Paul Magnusson


Commentary: Smallpox: Who Should Be Immunized?

 
  STORY TOOLS
Printer-Friendly Version
E-Mail This Story

Related Items Table: Why the Virus Strikes Terror

Short of a nuclear missile attack, nothing would be quite as devastating to America as a half-dozen terrorists loose in urban subways with containers of airborne smallpox germs. In a worst-case scenario, hundreds of unwitting commuters would soon experience flu-like fevers and aches lasting for about two weeks. Before the first disfiguring skin pox appear, the victims would spread the deadly virus to others. Within one month, an epidemic would rage out of control, killing one-third of the people infected. Of the remainder, one-tenth would be blinded, and many more terribly scarred.


The U.S. government can't guarantee that such an attack won't occur, but it will soon have the means to thwart the terrorists. By the fall, U.S. stockpiles of smallpox vaccine will reach nearly 300 million doses, enough for the entire population. Then, the Bush Administration will have to choose among a range of options. It can permit the vaccination of up to 20,000 medical personnel, as recommended on June 20 by an advisory medical panel. Or it could heed Richard Levinson at the American Public Health Assn. and "immunize everyone as quickly as possible." The best approach, however, is a middle path that has received little attention: allow carefully screened, healthy adults to volunteer for vaccination. "The more volunteers you vaccinate, the slower the spread of any disease through the general population, and the more time you have to vaccinate the rest," says William J. Bicknell at the Boston University School of Public Health.

For now, the government plans to stick with a tried-and-true approach called "ring containment." The idea: treat the sick and vaccinate anyone they may have come in contact with. This approach was last used in the U.S. in 1947 when an infected businessman arrived from Mexico by bus in New York City. Authorities vaccinated more than 6 million people in a month. Only 12 contracted the disease, and just two died.

The trouble is, ring containment is based on a chance outbreak, not a terrorist attack. "It is not going to work against a thinking agency like al Qaeda in a highly mobile, concentrated, and unvaccinated society," says Randall J. Larsen, director of the ANSER Institute for Homeland Security, a Washington think tank. Forced to respond to a series of attacks in different cities, health officials would be quickly overwhelmed.

So why not just vaccinate everyone and stop worrying? Two big reasons: Scientists estimate that mass vaccinations could lead to unacceptably high rates of complications--up to four deaths per million from encephalitis and other maladies, as well as lesser skin rashes. Secondly, the vaccine is itself a live virus, albeit far less harmful than smallpox, and it's contagious. In past immunization programs, 20% of those suffering vaccine-related symptoms had not been inoculated themselves. "That's what makes it a societal decision and not just a personal choice," says D.A. Henderson, a U.S. scientist who led the worldwide fight to stamp out smallpox in the 1970s.

The middle path addresses both objections. Screening out people whose immune systems are already damaged by AIDS or cancer treatments, while barring young children, could cut vaccine-related deaths to an estimated one in a million, says Bicknell. In addition, vaccinated volunteers would naturally produce a substance in their blood called vaccinia immune globulin, which could be harvested and administered as a therapy to people suffering mild complications.

The risk of a terrorist attack can't be quantified. But homeland security experts note ominously that both Iraq and North Korea vaccinate at least some of their military, suggesting that they may have stockpiles of smallpox. And Russians once produced tons of highly weaponized forms of the virus, some of which may now be in terrorists' hands.

There are no easy answers, allows Henderson. He advocates a cautious approach, noting that "this is a risk-averse society." That's true. But it's also why the government ought to allow some voluntary vaccinations, and let people decide for themselves if the risk is worth the taking.



Magnusson covers homeland security from Washington, D.C.


Get BusinessWeek directly on your desktop with our RSS feeds.XML

Add BusinessWeek news to your Web site with our headline feed.

Click to buy an e-print or reprint of a BusinessWeek or BusinessWeek Online story or video.

To subscribe online to BusinessWeek magazine, please click here.

Learn more, go to the BusinessWeekOnline home page

Back to Top

JULY
TODAY'S MOST POPULAR STORIES

  1. XM-Sirius: Land Mines Aplenty
  2. S&P Puts Fannie and Freddie on Credit Watch Negative
  3. How Can The New York Times Be Worth So Little?
  4. The Real Question: Should Oil Be Cheap?
  5. Cash for Trash

Get Free RSS Feed >>
  MARKET INFO
DJIA 11370.69 +21.41
S&P 500 1257.76 +5.22
Nasdaq 2310.53 +30.42

Portfolio Service Update

Stock Lookup

Enter name or ticker



Media Kit | Special Sections | MarketPlace | Knowledge Centers
McGraw-Hill Cos.